Supplementary Figure S3 from Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts

• DOI: 10.1158/2767-9764.25436370.v1
• Publication Date: 2024-03-19T14:25:02Z
• Authors: Yasuhiro Arakawa; Ukhyun Jo; Suresh Kumar; Nai-Yun Sun; Fathi Elloumi; Anish Thomas; Nitin Roper; Diana Grace Varghese; Naoko Takebe; Xiaohu Zhang; Michele Ceribelli; David O. Holland; Erin Beck; Zina Itkin; Crystal McKnight; Kelli M. Wilson; Jameson Travers; Carleen Klumpp-Th...; Craig J. Thomas; Chuong D. Hoang; Jonathan M. Herna...; Jaydira Del Rivero; Yves Pommier
• Keywords: Organoid; Carcinoma Cell

<p>Synergistic effect of TAK-243 on Navitoclax. Analysis synergistic effects using the MTT assay.</p>